Peptides Factory Direct See pricing & order
Home / Reference / Adamax
Cognitive / Neuro - SubQ / Intranasal research

Adamax Research Reference

Adamax is a synthetic nootropic peptide analog discussed in neuroprotection and cognitive-performance research, with proposed modulation of neurotrophic signaling, oxidative stress, and neur...

Research reference only. This is an educational, mechanism-level reference for an investigational research compound - not medical advice, a prescription, or a protocol to follow. Reconstitution, dosing, and pharmacokinetic figures are research-reference values for laboratory context only. Products are research-use-only, not for human or animal consumption, and not FDA approved. Confirm all concentration math and review with a qualified clinician before any formal research use.
See live pricing, stock & bundles for Adamax

Create a free research account to view current pricing and place an order.

See live pricing & order →

Mechanism of action

Adamax is a synthetic nootropic peptide analog discussed in neuroprotection and cognitive-performance research, with proposed modulation of neurotrophic signaling, oxidative stress, and neuronal resilience pathways.

Half-life & pharmacokinetics

Half-life: Short acting.

Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.

Research dosing reference

250-1000 mcg daily depending on cognitive research objective.

Dose interpretation (U-100 units)

Target doseU-100 units
250 mcg10 units
500 mcg20 units
1000 mcg40 units

Units are concentration-specific - confirm against your actual reconstitution volume.

Reconstitution & concentration

VialPreferred reconstitutionFinal concentration
5 mg2 mL BAC Water0.025 mg/unit

Injection timing

Daytime or situational use is common unless sleep-specific. Avoid first-time use before critical tasks until response is understood.

Beginner escalation

Titrate based on sedation, stimulation, headache, focus, sleep quality, or emotional response. More is not always better with neuroactive peptides.

Side-effect mitigation

Monitor headache, fatigue, paradoxical stimulation, sedation, sleep disruption, or emotional flattening. Avoid overlapping multiple neuroactive agents initially.

Stack compatibility

May pair with complementary neuropeptides, mitochondrial agents, or sleep protocols, but single-variable testing is preferred for interpretability.

Storage & stability

Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.

Protocol duration & reassessment

Use short, interpretable blocks or situational protocols. Reassess after 2-4 weeks for sleep, mood, focus, headaches, stimulation/sedation, and whether continued use is justified.

Frequently asked questions

What is Adamax and how does it work?

Adamax is a synthetic nootropic peptide analog discussed in neuroprotection and cognitive-performance research, with proposed modulation of neurotrophic signaling, oxidative stress, and neuronal resilience pathways.

What is the half-life of Adamax?

Adamax: Short acting. Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.

How is Adamax reconstituted for research?

Preferred reconstitution for the 5 mg vial is 2 mL BAC Water, giving 0.025 mg/unit. Always confirm concentration math before any use. Research use only.

Is Adamax FDA approved?

No. Adamax is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.

All research reference · Research guides

External references: Peptide (Wikipedia) · U.S. Food and Drug Administration

Adamax is an investigational research-use-only compound, not for human or animal consumption, not FDA approved, and not intended to diagnose, treat, cure, or prevent disease. This reference is not medical advice.